Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Highly effective infusion for MS with a risk of PML. | First oral therapy for relapsing multiple sclerosis. |
| Body system | Brain & Nerves | Brain & Nerves |
| Drug class | Multiple sclerosis therapies | Multiple sclerosis therapies |
| Supply | Prescription only | Prescription only |
| Main uses | Relapsing MS, Crohn's disease (US) | Relapsing MS |
| How it works | Stops immune cells from entering the brain. | Keeps immune cells from reaching the brain and spinal cord. |
| Starts working | Weeks to months | Weeks to months |
| Half-life | About 11 days | 6–9 days |
| Typical adult dose | 300 mg IV once every 4 weeks (every 6 weeks in some regimens). | 0.5 mg once a day. |
| Forms | Monthly IV infusion | Capsule |
| Common side effects | Headache, Tiredness, Urinary infection, Joint pain | Headache, Cough, Diarrhoea, Raised liver enzymes, Back pain |
| Serious side effects | PML (rare brain infection), Liver injury, Allergic reactions | Slow heart rate after the first dose, Serious infections, Macular oedema, PML (rare), Skin cancer |
| Don't take if | Active serious infection; PML history; Immunosuppression | Recent heart attack or stroke; Heart block or QT prolongation; Active infection; Pregnancy |
| Alcohol | Usually no problem in moderation. No known interaction. | Best to limit. Alcohol adds to liver stress. |
| Pregnancy | Use with cautionLimited data; specialist decision. | Usually avoidedHarmful to the baby; effective contraception needed. |
| Breastfeeding | Use with cautionUnknown amounts in milk. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: TysabriUnited Kingdom: TysabriIndia: Tysabri | United States: GilenyaUnited Kingdom: GilenyaIndia: Gilenya, Fingolimod (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L04AG03 | L04AA27 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker